Signaling by extracellular purines such as ATP and adenosine has implications for dental research on multiple levels, with the association of purinergic signaling with inflammation, mechanical strain, and pain making the system particularly relevant for the specific challenges in the oral cavity. Oral tissues express a variety of G-protein-coupled P2Y receptors for ATP and P1 receptors for adenosine in addition to ionotropic P2X receptors for ATP. When these receptors are combined with the plethora of extracellular enzymes capable of manipulating extracellular agonist levels, a complex system for regulating oral health emerges, and recent findings have begun to identify a key role for purinergic signaling in oral pathophysiology. For example, the manipulation of extracellular ATP levels by P. gingivalis reduces inflammasome activation and apoptosis linked to P2X 7 receptor activation. Release of ATP by periodontal ligaments may link mechanical strain to bone remodeling. Activation of P2X receptors is implicated in dental pain, and receptor antagonists represent important targets for new analgesics. Altered levels of adenosine receptors in periodontal disease also suggest a role for nucleosides in dental signaling. The intricacies of the purinergic signaling system make it well-suited for the unique concerns of dental research, and future findings will doubtless confirm this importance.
KEY WOrDs: P2X7, P2Y, inflammasome, periodontal disease, neurotransmitter, mechanosensitivity. IntrODuctIOn t he purinergic signaling system is involved in a wide range of physiological processes that have an impact on dental systems, including bone remodeling (Orriss et al., 2010) , neuronal signaling , inflammation (Ohta and Sitkovsky, 2009) , epithelial transport (Novak, 2011) , and stem cells (Burnstock and Ulrich, 2011) . While a role for purines in oral tissues has been acknowledged for over a decade , there has been a recent burst of new information pertaining to purinergic aspects of dental research. This review will provide a brief overview of purinergic systems before describing some of the recent findings with considerable impact on oral science.
bAsIc PrIncIPlEs Of PurInErgIc sIgnAlIng
Purinergic signaling refers to the process by which purines and pyrimidines mediate cellular responses following stimulation of specific receptors. The presence of purinergic receptors in primitive multicellular organisms (Fountain and Burnstock, 2009) , combined with wide dispersal of purinergic receptors throughout the body, reflects their central role in numerous physiological and pathophysiological processes (Burnstock and Knight, 2004) .
Purinergic receptors are divided into 2 main categories, termed P1 and P2 receptors ( Fig. 1 ; Burnstock, 1978) . P1 receptors respond predominantly to the nucleoside adenosine (Fredholm et al., 2011) . The A 2A and A 2B adenosine receptors are coupled to the G s protein, with stimulation leading to the activation of adenylate cyclase and increased levels of cytoplasmic cAMP. The A 1 and A 3 receptors are coupled to the G i protein, with activation leading to the inhibition of adenylate cyclase and consequently a reduction in cAMP. In addition to effects on adenylate cyclase, these receptors are differentially coupled to other G proteins and induce various downstream reactions on calcium and kinases (Klinger et al., 2002) .
P2 receptors are primarily activated by nucleotides and are further divided into the P2X family of ionotropic cation channels and the P2Y family of G-protein-coupled receptors (Burnstock and Kennedy, 1985; Coddou et al., 2011; von Kugelgen and Harden, 2011) . The 7 cloned P2X receptors, termed P2X 1..7 , differ in their rates of inactivation and sensitivity to agonist ATP, with the P2X 7 receptor requiring the highest concentrations of ATP for activation and inactivating most slowly (North, 2002) . The 8 mammalian P2Y receptors differ in their optimal agonist, with ATP, ADP, UTP, UDP, and UDP glucose preferentially activating particular receptors (Abbracchio et al., 2006) . P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , and P2Y 14 receptors are coupled to G q / 11 , while P2Y 4 , P2Y 12 , and P2Y 13 are coupled to G i and P2Y 11 is coupled to G s . This variety of agonists and effectors ensures that purinergic signaling can affect an enormous number of processes in different tissues.
The functional breadth of purinergic signaling is enhanced by the ability of most cell types to release sufficient ATP to stimulate at least some of these receptors. While ATP is used by neurons as a neurotransmitter, purines are also used for local signaling between and among many non-neuronal cell types (Burnstock, 1999; Fitz, 2007) . Release is used to convey information to neighboring cells through paracrine signaling or to amplify information through autocrine networks (Lazarowski et al., 2011) . Every cell has a supply of cytoplasmic ATP and can release it to communicate. ATP can be released under physiological conditions through fusion of ATP-containing vesicles with the plasma membrane in classic release pathways, or, alternatively, ATP can flow down its electrochemical gradient through permeant pores or channels. The calcium-dependent fusion of vesicles containing permeant channels with the plasma membrane represents a hybrid mechanism and may explain the sometimes contradictory results (Reigada and Mitchell, 2005) . Anion channels, connexin hemichannels, and pannexin hemichannels have been implicated as conduits for the passive efflux of ATP out of the cell. Multiple release mechanisms may also exist within the same cell, activated by different stimuli, with release frequently triggered by mechanical perturbations (Xia et al., 2012) . Under more terminal pathological conditions, cell lysis releases cellular contents including ATP into the extracellular milieu (Cook and McCleskey, 2002) .
Released ATP is rapidly dephosphorylated by a series of extracellular enzymes to ADP, AMP, and adenosine (Fig. 1 ). The ectonucleotidase (NTPDase) family of enzymes facilitates single or double dephosphorylations, while the ectonucleotide pyrophosphatase/phosphodiesterase (EPP) family converts ATP directly into AMP and pyrophosphate (Goding et al., 2003; Zimmermann, 2006) . Additional extracellular enzymes such as ecto-nucleoside diphosphokinases can alter levels by interchanging terminal phosphates between purines and pyrimidines (Lazarowski et al., 1997) . Adenosine is removed from extracellular space following conversion to inosine by adenosine deaminase or uptake by adenosine transporters (Thorn and Jarvis, 1996) . Since ATP and adenosine can induce opposite effects on cell survival , and since ectoenzymes can be located close to ATP release sites (Joseph et al., 2003) , the regulation of these ectoenzymes can control the effective concentration of agonists and thus the relative effect on a given receptor (Kukulski et al., 2011) .
PAthOPhYsIOlOgIcAl rOlEs Of PurInErgIc sIgnAlIng
The ubiquitous expression of purinergic receptors, the presence of various release mechanisms, and the plethora of enzymes capable of modifying extracellular purines and pyrimidines attest to their key role in cellular function throughout the body. Since this response involves defending the body and alerting it to potentially damaging insults, purinergic signaling has also evolved to be a central participant in pathophysiology. Of particular focus with regard to dental tissues is the role of purines in inflammation and pain ( Fig. 2) .
Stimulation of adenosine receptors has multiple effects on inflammatory signaling (Hasko et al., 2008; Ferrero, 2011) . The release of IL-10 from macrophages exposed to E. coli requires a functioning adenosine A 2A receptor (Csoka et al., 2007) , while cytokine release from mast cells is influenced by stimulation of the A 2B receptors (Auchampach et al., 1997) . Agonists for the A 3 adenosine receptor may be effective at reducing inflammation in rheumatoid arthritis (Silverman et al., 2008) and are currently being evaluated in clinical trials. Recent attention also highlights the analgesic actions of adenosine, with both direct stimulation of P1 receptors and elevated extracellular adenosine levels following increasing ectonucleotidase activity of potential benefit (Zylka, 2011) . Of particular interest is the demonstration that A 1 adenosine receptors contribute to the analgesic effect of acupuncture (Goldman et al., 2010) .
Extracellular ATP has long been known for its pivotal role in inflammation, and responses involve both P2X and P2Y receptors (Ferrero, 2011) . Mechanosensitive release of IL-6 into the airway lumen involves ATP release and autostimulation of the P2Y 1 receptor via activation of phospholipase C and p38 MAPK (Douillet et al., 2006) . The response to leukotriene E4 in pulmonary cells associated with asthma is dependent upon the P2Y 12 receptor (Paruchuri et al., 2009 ). Activation of the P2X 7 receptor and inflammation is widespread, with stimulation of the receptor leading to the opening of a large-diameter pore in some cases (Lister et al., 2007) . The P2X 7 receptor has also been linked to the inflammasome, whereby efflux of K + through the channel triggers the NALP3 inflammasome, resulting in activation of caspase 1 and subsequent cleavage of pro-IL-1β into releasable mature IL-1β (Stutz et al., 2009) . The P2X 4 receptor has been implicated in inflammatory pain; activation of the arachidonic acid cascade following treatment with complete Freund's adjuvant was substantially reduced in P2X 4 -/mice; release of PGE 2 from macrophages followed calcium influx through the P2X 4 receptor channel, p38 MAPK phosphorylation, and phospholipase A activation (Ulmann figure 1. ATP is released from cells passively through pores like pannexin and connexin hemichannels, or Cl-channels. Alternatively, ATP can be stored in vesicles and released via fusion with the plasma membrane. Extracellular ATP can stimulate ligand-gated P2X receptor ion channels or G-protein-coupled P2Y receptors. ADP, UTP, and UDP processed by extracellular enzymes (E) can also stimulate P2Y receptors.
Additional processing by ectonucleotidases, ectonucleosidases, ectonucleotide pyrophosphatases, and ectodiphosphokinases can produce extracellular adenosine. Adenosine can stimulate G-protein-coupled A 1 , A 2A , A 2B , or A 3 receptors to induce additional responses. These receptors can be present on cells neighboring those releasing the ATP for paracrine signaling, or on the same cells under autocrine signaling pathways. et al., 2010) . This adds to the welldocumented involvement of P2X 3 (North, 2004) , P2X 7 (Donnelly-Roberts and Jarvis, 2007), and P2Y receptors (Gerevich and Illes, 2004) in the detection and transmission of pain.
AtP AnD gIngIvAl cElls
A substantial role for ATP in the pathophysiology of gingival epithelial cells (GECs) has emerged over the past few years. GECs express mRNA for the P2X 2 , P2X 4 , P2X 5 , P2X 6 , and P2X 7 receptors, with the expression of the P2X 7 receptor confirmed immunohistochemically (Yilmaz et al., 2008) . Extracellular ATP increased rates of apoptosis, with death prevented by the P2X antagonist oxidized ATP and induced by the P2X 7 R agonist BzATP. However, inclusion of P. gingivalis with the ATP reduced the apoptosis of GECs. An ecto-nucleoside diphosphate kinase was identified in the P. gingivalis genome, and a mutant strain deficient in the secreted enzyme was created. ATP hydrolysis was lower in this mutant strain, consistent with the hydrolysis of extracellular ATP by the nucleoside diphosphate kinase. In contrast to the wild type, this mutant P. gingivalis did not inhibit apoptosis of GECs induced by extracellular ATP. The P2X 7 R is associated with the activation of a large pore permeable to molecules up to approximately 800 kDa (Surprenant et al., 1996) . While ATP increased uptake of the large fluorescent dye Lucifer Yellow into GECs, infection with wild-type P. gingivalis inhibited the ATP-evoked LY uptake. However, dye uptake was larger in cells infected with the mutant strain, and recombinant nucleoside diphosphate kinase itself inhibited dye uptake. The authors proposed that infection would normally trigger apoptosis of the GECs by stimulation of the P2X 7 receptor by ATP, but that P. gingivalis prevented this apoptosis by reducing extracellular ATP levels with secreted nucleoside diphosphate kinase (Yilmaz et al., 2008) .
P. gingivalis interferes with the inflammatory response in GECs by manipulating the activation of the P2X 7 R (Yilmaz et al., 2010) . While infection of GECs with P. gingivalis enhanced expression of IL-1β message and levels of pro-IL-1β, secretion of IL-1β required subsequent exposure to ATP. Caspase 1 was activated after stimulation with ATP, while knockdown of NALP3 mRNA reduced IL-1β secretion, implicating the inflammasome. NALP3 gene expression was down-regulated after P. gingivalis infection. Together, these reports suggest that the P2X 7 R usually plays a key role in amplifying the inflammatory signal from GECs to contain infection (Fig. 2) . By hydrolyzing extracellular ATP, P. gingivalis reduces apoptosis and the secretion of IL-1β to override the natural defenses of the cells.
Stimulation of the P2X 7 R in gingival fibroblasts was also implicated in the up-regulation of IL-8 by the antimicrobial peptide LL-37 (Montreekachon et al., 2011) . LL-37 can attract leukocytes and up-regulate immune-related genes in various cell types (Zanetti, 2004) , and levels of LL-37 are perturbed in periodontitis (Puklo et al., 2008) . LL-37 up-regulated IL-8 through a pathway sensitive to MEK, p44/42 MAP kinase inhibitors, and P2X antagonists. Inhibition of P2X 7 R with antagonist Brilliant Blue G blocked the up-regulation and secretion of IL-8 by LL-37. Whether this activation by LL-37 is mediated by an increase in ATP, or whether LL-37 augments the effect of existing ATP by partitioning into the membrane and modifying the receptor, as found elsewhere, remains to be fully resolved figure 2. Proposed purinergic signaling pathways underlying the cellular responses associated with P2 receptor activation in various areas of the tooth. The involvement of purinergic receptors in cytokine expression and secretion has been examined in dental pulp cells (P2Y 6mediated IL-6 release), in gingival fibroblasts (P2X 7 -mediated IL-8 release), and in gingival epithelial cells (inflammasome activation via ATP-ligation of P2X 7 R and caspase-1 cleavage of pro-IL-1β). In addition, hemichannels have been identified as a potential conduit for ATP release from periodontal ligament cells, with stimulation of P2Y 1 R leading to up-regulation of osteopontin and receptor activator of nuclear factor kappa B ligand (RANKL). Homomeric P2X 3 receptors and/or heteromeric P2X 2 /P2X 3 receptors on nerve terminals in the dental pulp transmit nociceptive signals upon stimulation by ATP released from numerous neighboring sources. (Elssner et al., 2004; Tomasinsig et al., 2008) . Regardless, the involvement of LL-37 may represent an important link between enhanced inflammation and purinergic signaling. The recent observation that the P2Y 12 antagonist clopidogrel (Plavix) reduced levels of IL-6 and TNF-α in a rat model of periodontal disease supports the pro-inflammatory role of extracellular ATP (Coimbra et al., 2011) .
AtP AnD PErIODOntAl lIgAmEnts
In periodontal ligaments, ATP has been shown to link mechanical strain to osteopontin and the receptor activator of nuclear factor kappa-B ligand (RANKL; Fig. 2 ). Mechanical stress led to an up-regulation of osteopontin at mRNA and protein levels in human periodontal ligament cells (PDLs; Wongkhantee et al., 2008) . Osteopontin anchors osteoclasts to the surface so they can contribute to bone resorption and may be modified in periodontal disease (Sharma and Pradeep, 2006) . The mechanosensitive release of osteopontin release was inhibited by the P2 receptor antagonists suramin and NF449 and specific P2Y 1 R receptor antagonist MRS2179, implicating an autocrine stimulation of P2Y 1 R by ATP (Wongkhantee et al., 2008) . The extracellular medium from stretched cells triggered an increase in osteopontin mRNA and protein expression; this medium had increased levels of ATP, and the increase in osteopontin was prevented by the soluble ecto-ATPase apyrase. The addition of ATP was sufficient to increase osteopontin expression, confirming the role of extracellular ATP in the response.
Extracellular ATP was also implicated in the stimulation of the receptor activator of nuclear factor kappa-B ligand (RANKL) in PDLs following stimulation of the P2Y 1 R (Luckprom et al., 2010) . The ATP-induced nuclear translocation of factor NFκB contributed to RANKL up-regulation. Since RANKL is central to osteoclast activation (Theill et al., 2002) , the up-regulation of both osteopontin and RANKL suggests that release of ATP following mechanical strain on PDL cells could alter the homeostasis of the periodontium by altering bone resorption.
The mechanism underlying the mechanosensitive efflux of ATP from periodontal ligaments has been proposed to involve hemichannels (Luckprom et al., 2011) . ATP release was prevented by the inhibitors carbenoxelone and meclofenamic acid and by connexin 43 knockdown with siRNA, although a contribution through pannexin channels was not ruled out. While an influx of carboxyfluorescein was observed after mechanical strain, consistent with the opening of a large-pore channel, this fluorescence uptake was reduced by meclofenamic acid. Heparin, thapsigargin, and 2-APB also inhibited ATP release, suggesting a role for intracellular calcium. Since the mechanosensitive release of ATP from periodontal ligaments precedes the involvement of OPN and RANKL, discussed above, inhibition of this release through the hemichannels may provide a common target.
Purines also modulate the proliferation of human periodontal ligament cells in culture (Kawase et al., 2007) . Prolonged incubation with at least 50 µM of the slowly hydrolyzable ATPγS increased caspase 3/7 levels and TUNEL staining. The corresponding reduction in viable cell number was attributed to induction of apoptosis through ATPγS acting at P2 receptors.
Addition of hydrolyzable ATP did not activate apoptosis; the mechanism by which ATP reduced proliferation remains to be determined, but may involve modulation of cell-cycle proteins. The difference in effects between purine agonists was attributed to rapid hydrolysis of ATP; levels of the ectoATPase NTPDase1 (CD39) on PDL cells were considerable and increased with time in culture.
P2 rEcEPtOrs AnD DEntAl PAIn
Purines make a major contribution to the transmission of pain from the oral cavity (Fig. 2) . This involvement has been known for many years; in fact, the demonstration that low concentrations of ATP initiated action potentials in nociceptive neurons from dental pulp was one of the earliest reports linking purinergic signaling and the P2X 3 receptor to pain anywhere in the body . The currents activated by ATP in these neurons had both a rapidly inactivating and more sustained component . Rat neurons express the P2X 3 receptor in sensory endings . In the pulp obtained from human third molars, neurofilament-positive nerve fibers staining for the P2X 3 receptor were detected in close association with odontoblasts (Alavi et al., 2001) . Mechanical distortion of the odontoblasts was thought to lead to ATP release and a painful sensation after stimulation of the P2X 3 receptors on these neurons. P2X 3 receptor staining was also detected in the subodontoblastic plexus of Raschkow and in the pulp center. Expression of the P2X 3 receptor was confirmed in both myelinated and unmyelinated nerve fibers of human tissue (Sharma and Pradeep, 2006) . In rats, P2X 3 receptors were detected in both pulp and substance-P-negative cells in the trigeminal ganglion, suggesting a distinct population of pain-sensing afferent fibers (Jiang and Gu, 2002) . Antagonists to the homomeric P2X 3 receptor and/or the heteromeric P2X 2 /P2X 3 receptors in the trigeminal subnucleus caudalis prevented sensitization following application of mustard oil to the dental pulp, suggesting involvement of the receptor in the amplification of pain signaling through secondary-level circuits (Hu et al., 2002) . More recently, the contribution of ATP to dental pain was supported by findings that the P2X 3 receptor agonist α,β-meATP enhanced genioglossus muscle contraction and phosphorylated ERK in the trigeminal spinal subnucleus and caudalis paratrigeminal nucleus, with both responses being inhibited by antagonist TNP-ATP (Adachi et al., 2010) . The enhanced expression of P2X 3 receptors on sensory neurons as compared with extracranial neurons suggests that they may provide good targets for the reduction of pain (Ambalavanar and Dessem, 2009) . ATP is co-released from the trigeminal ganglia with substance P (Matsuka et al., 2001) , while both P2X 2 and P2X 3 receptors are expressed in trigeminal ganglion nerves (Staikopoulos et al., 2007) .
Purines also contribute to temporomandibular joint (TMJ) pain. The P2X 3 receptor is expressed in the TMJ (Ichikawa et al., 2004) , and injection of the P2X agonist α,β-meATP into the rat TMJ increased behavioral nociceptive responses, while blockage of P2X receptors with antagonist PPADS decreased the inflammatory hyperalgesia accompanying injection of carrageenan into rat TMJ (Oliveira et al., 2005) . P2X receptors also contribute to reflexive actions in the TMJ, since the antagonist α,β-meATP reduced the reflex response (Watanabe et al., 2010) . Given the role of purinergic receptors in inflammation (Ferrero, 2011) and the importance of inflammation in the TMJ (Sessle, 2011) , it is likely that purines may also contribute here, although there was no change in the expression of the P2Y 12 receptor from microglia in rat models of TMJ inflammation (Villa et al., 2010) .
While these studies suggest that the development of new P2X 3 antagonists may be of benefit in the treatment of oral pain, the receptor may be involved in the effects of traditional analgesics. For example, eugenol has been used throughout history to reduce oral pain (Markowitz et al., 1992) . However, eugenol reversibly inhibited ATP-induced P2X current in both capsaicinsensitive and capsaicin-insensitive neurons, implying actions independent of Trp channels (Li et al., 2008) . The P2X agonist α,β-meATP induced a Ca 2+ transient in capsaicin-insensitive neurons, which was blocked by eugenol. Eugenol was previously found by this group to antagonize voltage-gated calcium currents in dental afferent neurons (Lee et al., 2005) . It is conceivable that ATP released as a result of inflammatory and/or mechanical stimulation would open P2X 3 receptors, and that the corresponding influx of cations would depolarize the membrane sufficiently to activate the voltage-dependent calcium channels, although this remains to be tested directly.
PurInEs, InflAmmAtOrY sIgnAls, AnD bOnE lOss
In addition to stimulating nociceptive receptors, the mechanosensitive release of ATP may also affect cytokine signaling from human dental pulp cells. Dental pulp cells exposed to compressive forces displayed a proportional increase in expression and release of IL-6 (Satrawaha et al., 2011) . The IL-6 response was both rapid and sustained, with enhanced IL-6 release maintained for at least 24 hrs. Pharmacological experiments identified the P2Y 6 receptor as mediating the pressure-induced increase in both IL-6 mRNA and release of protein. Incubation with the P2Y 6 R agonist UDP, but not UTP or ATP, mimicked the response. UDP levels can be modulated by phosphate transfer by ecto-nucleoside diphosphokinase (Lazarowski et al., 1997) . It would thus be interesting to determine whether levels of this enzyme were altered in pulp subject to chronic pressure.
Excessive ATP acting at P2X 4 receptors may contribute to the bone loss found after periodontal surgery (Binderman et al., 2007) . Message levels for the receptor were increased rapidly after surgery, with the most intense antigen staining in the connective tissue of marginal gingiva and periodontal ligaments. Extracellular ATP was implicated in the bone loss, since loss was reduced by the soluble ecto-nucleotidase apyrase. Bone loss was prevented by the P2X antagonists Coomassie Brilliant Blue R and G. Coomassie Brilliant Blue has an IC 50 at rat P2X 7 receptors of 100 nM and at rat P2X 4 receptors of 100 µM (Jiang et al., 2000) . The ability of Brilliant Blue G to reduce bone loss after periodontal surgery at 100 µM, but not in the nanomolar range, implicates the P2X 4 receptor. The authors logically concluded that bone loss may be minimized by reducing the ability of extracellular ATP to stimulate the P2X 4 receptor. This remains a promising avenue for treatment as specific antagonists are developed (Donnelly-Roberts et al., 2008) .
ADEnOsInE AnD sIgnAlIng In DEntAl cElls
Much less attention has thus far been paid to the actions of adenosine on P1 receptors in dental cells than to ATP on P2 receptors. However, several indications suggest this as a promising area for future development. Levels of adenosine on human gingival fibroblasts are regulated by its production by ecto5nucleotidase (CD73) and reduction by ecto-adenosine deaminase (Hashikawa et al., 2006) , suggesting that regulation of adenosine levels may contribute to the pathology. Human gingival fibroblasts have been reported to express A 1 , A 2A , and A 2B , but not A 3 , mRNA (Murakami et al., 2001) . It is worth noting that message for the A 3 AR is often expressed at low levels, and the receptor has been identified in tissues where the initial detection at the molecular level was missed (X . Stimulation of the A 2B AR in human gingival fibroblasts upregulated IL-6 production (Murakami et al., 2000) , while stimulation of A 2A AR receptors increased IL-1β-induced IL-6 and IL-8 production and the expression of hyaluronate synthase (Murakami et al., 2001) . Recently, it was suggested that the level of mRNA coding for adenosine receptors was altered in humans with chronic periodontitis, with levels of the A 1 AR and A 3 AR levels down, and levels of A 2A AR and A 2B AR increased (Sun et al., 2011) . Given the large number of pharmacological tools available with which to probe adenosine receptors (Gao and Jacobson, 2011) , the effects of adenosine receptors are likely to be a topic of considerable interest to dental research in the future.
mAnY AvEnuEs fOr futurE rEsEArch
The dental research community's recent interest in purinergic signaling is fitting, given the overlapping focus on inflammation and pain. Several key studies have demonstrated the potential importance of this signaling, and suggest that stimulation by ATP, adenosine, and related compounds will affect many additional facets of dental pathophysiology. Given the number of agonists, antagonists, and modulators under development, it is likely that, in the near future, purinergic receptors will become key pharmacological targets for the treatment of oral pathologies.
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